Chiltern

Chiltern, Charles River Labs Partner on Early-phase Studies

Friday, February 26, 2010 06:54 AM

UK contract research organization (CRO) Chiltern International and preclinical CRO Charles River Laboratories are partnering to conduct and support early-phase radiolabelled studies.

More... »

Chiltern Opens Office in Argentina

Thursday, February 18, 2010 03:26 PM

UK-based Chiltern International opened a new, larger office in Argentina, replacing the contract research organization’s (CRO’s) existing facility in that country. This is Chiltern’s fifth new office to open in the past year. The CRO opened offices in Hungary, Belgium, Scotland and Brazil in 2009.

More... »

Phase Forward Appoints First Chief Privacy Officer

Thursday, December 24, 2009 07:40 AM

Phase Forward appointed long-time employee Michael Owings to the new role of chief privacy officer. Owings will oversee all privacy and data protection processes affecting Phase Forward’s customers and employees, and ensure compliance with all relevant regulations. He will also continue his duties as vice president, quality and regulatory compliance—a title he’s held since 2004.

More... »

Czura Thornton to Buy MDS Central Lab Business

Monday, October 19, 2009 07:46 AM

Czura Thornton, the private investment group that already owns UK-based contract research organization (CRO) Chiltern International, has agreed to acquire the global central laboratory operations of MDS Pharma Services for about $8 million. 

More... »

Chiltern Acquisitions Contribute to 44% Revenue Increase

Friday, July 17, 2009 09:06 AM

Chiltern International reported a 44% revenue increase for the year ended March 31, 2009, due in large part to acquisitions. The UK-based CRO attributed 15% of its growth to acquisitions, including the recent acquisition of Brazil CRO Vigiun.

More... »

Chiltern Opens Hungary Office

Wednesday, July 8, 2009 07:23 AM

UK-based contract research organization (CRO) Chiltern International opened a new office in Budapest, Hungary.

More... »

Global Acquisitions Heat Up

Monday, April 27, 2009 08:00 AM

Three companies—Phase Forward, Chiltern International and ChemDiv—are the latest clinical trial companies to complete global acquisitions.

More... »

Chiltern Acquires Brazil CRO Vigiun

Tuesday, April 21, 2009 07:58 AM

UK-based contract research organization (CRO) Chiltern International continued its global expansion efforts with the acquisition of Vigiun, a CRO in São Paulo, Brazil, for an undisclosed amount.

More... »